These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 479785)

  • 1. Rubella seroconversion following immunization in a rural practice.
    Hough JC; Walker RB; Brough JW
    J Fam Pract; 1979 Oct; 9(4):587-9. PubMed ID: 479785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR; Abramson JS; Harlan JE; Kelsey DS
    Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rubella epidemiology in rural Upper Volta].
    Monjour L; Druilhe P; Huraux JM; Palminteri R; Froment A; Kyelem JM; Alfred C; Laplace JL; Gentilini M
    Acta Trop; 1982 Sep; 39(3):247-52. PubMed ID: 6128893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of congenital rubella and the immunity status to rubella in the Jerusalem area.
    Isacsohn M; Rudensky B; Eidelman AI; Paz E; Weintraub G; Nubani N; Swartz TA
    Isr J Med Sci; 1983 Oct; 19(10):929-33. PubMed ID: 6363348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success and failure of a rubella immunization programme.
    Swartz TA; Porath EB; Hornstein L
    Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.
    Rafnar B
    Bull World Health Organ; 1982; 60(1):141-6. PubMed ID: 6979417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella antibodies in women of childbearing age during an epidemic and the two years thereafter.
    Hornstein L; Ben-Porath E
    Isr J Med Sci; 1976 Oct; 12(10):1189-93. PubMed ID: 990135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The seroepidemiology of rubella: the independent analysis of current prevalence and past incidence in serological surveys in Spain.
    Najera E; Najera R; Gallardo FP
    Bull World Health Organ; 1973; 49(1):25-30. PubMed ID: 4545153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups.
    Baba K; Yabuuchi H; Okuni H; Harima R; Minekawa Y; Taniuchi M; Otsuka T; Takahashi M; Okuno Y
    Biken J; 1978 Mar; 21(1):25-31. PubMed ID: 666723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rubella prophylactic immunization problems in the Czechoslovak SSR: experiences with Ra 2713 and Cendehill rubella vaccines].
    Strauss J; Vodićková M; Domorázková E
    Z Gesamte Hyg; 1980; 26(5):360-2. PubMed ID: 7467541
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.